CISPLATIN COMBINATION CHEMOTHERAPY FOR DRUG-RESISTANT OVARIAN CARCINOMA
David S. Alberts(Los Angeles Medical Center), Nancy Mason, Ronald L. Stephens, Saul E. Rivkin(University of Puget Sound), Robert V. O’Toole(University of Maryland, Baltimore), Frank A. Mantz(University of Kansas), Robert D. Hilgers(University of New Mexico), Thomas E. Moon, Pierre W. Martimbeau
Cited by 1
Related Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
|Cancer|1984|397
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions
|Journal of Orthopaedic Research®|2019|313
Osteoid Osteoma and Osteoblastoma
|Clinical Orthopaedics and Related Research|1977|225